fashion -WSS

fashion

author：leisure time 2025-09-03 03:25:57 - browse：58

Amylyx founders — Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： 1 dead, 9 hurt in July 4th fireworks explosion

WSS

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Some in Scotland's Orkney Islands want to return to Norway after 550 years

GSK’s asthma push continues as drug succeeds in Phase 3 trials

EU climate chief is concerned over the expansion of the coal industry in China

Most antidepressants don't work on kids, teens, study finds

Novel spinal cord stimulator treats paralysis without surgery

focus

fashion

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Welsh Carson private equity firm escapes from FTC antitrust case

Jerome Adams on the need for new antivirals for Covid

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

In Memoriam: Notable people who died in 2023

US judge blocks portions of new Florida elections law

Hollywood unions extend contract negotiations for actors

The creative science of coining drug names

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Class action alleges UnitedHealth concealed DOJ probe

focus

AltruBio raises $225 million to develop ulcerative colitis drug

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

Can gargling with Listerine treat gonorrhea of the mouth?

HHS's proposed rule does nothing to address the climate crisis

Lawmakers grill UnitedHealth CEO on Change cyberattack

Some in Scotland's Orkney Islands want to return to Norway after 550 years

focus

knowledge

leisure time

entertainment